These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2282963)

  • 21. Non-canonical HIF-2α function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop.
    Stiehl DP; Bordoli MR; Abreu-Rodríguez I; Wollenick K; Schraml P; Gradin K; Poellinger L; Kristiansen G; Wenger RH
    Oncogene; 2012 May; 31(18):2283-97. PubMed ID: 21927022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A scintillation proximity assay for transforming growth factor alpha (TGF alpha).
    Hoffman R; Cameron L
    Biochem Soc Trans; 1991 Apr; 19(2):238S. PubMed ID: 1889604
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction of signaling and trafficking proteins with the carboxyterminus of the epidermal growth factor receptor.
    Carpenter G; Soler C; Baulida J; Beguinot L; Sorkin A
    Ann N Y Acad Sci; 1995 Sep; 766():44-51. PubMed ID: 7486689
    [No Abstract]   [Full Text] [Related]  

  • 24. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.
    Foekens JA; Portengen H; Janssen M; Klijn JG
    Cancer; 1989 Jun; 63(11):2139-47. PubMed ID: 2541884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelium and pericyte interdigitation: pathway for epidermal growth factor?
    Wakui S; Furusato M; Tanaka M; Allsbrook WC; Kano Y; Ushigome S
    Microvasc Res; 1990 Sep; 40(2):285-91. PubMed ID: 2250604
    [No Abstract]   [Full Text] [Related]  

  • 26. Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells.
    Wosikowski K; Silverman JA; Bishop P; Mendelsohn J; Bates SE
    Biochim Biophys Acta; 2000 Jul; 1497(2):215-26. PubMed ID: 10903426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FRETting about your receptors.
    Cliffe A
    Trends Cell Biol; 2001 Mar; 11(3):107. PubMed ID: 11306256
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on binding sites of epidermal growth factor in rat gastric mucosa].
    Fuse Y; Kawamoto K; Tsuji H; Takamasu M; Kodama T; Kashima T
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1479. PubMed ID: 2214273
    [No Abstract]   [Full Text] [Related]  

  • 29. DNA ploidy, cell kinetics, and epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer.
    d'Agnano I; Bucci B; Mottolese M; Benevolo M; Conti L; Botti C; Vecchione A; Casillo S; Zupi G
    Ann N Y Acad Sci; 1996 Apr; 784():472-81. PubMed ID: 8651601
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of epidermal growth factor in skin diseases.
    King LE; Ellis DL; Gates RE; Inman WH; Stoscheck CM; Fava RA; Nanney LB
    Am J Med Sci; 1988 Sep; 296(3):154-8. PubMed ID: 3052058
    [No Abstract]   [Full Text] [Related]  

  • 31. Derivation and assay of biological effects of monoclonal antibodies to epidermal growth factor receptors.
    Sato JD; Le AD; Kawamoto T
    Methods Enzymol; 1987; 146():63-81. PubMed ID: 3500387
    [No Abstract]   [Full Text] [Related]  

  • 32. [Epidermal growth factor receptors and their ligands as molecular markers of breast cancer prognosis and hormone sensitivity].
    Gershteĭn ES; Kushlinskiĭ NE; Dvorova EK; Kostyleva OI; Muaviia MA; Letiagin VP
    Klin Lab Diagn; 1998 Feb; (2):9-13. PubMed ID: 9553337
    [No Abstract]   [Full Text] [Related]  

  • 33. EGFs and ERBBs--brief history and prospects.
    Stern DF
    Semin Cell Dev Biol; 2010 Dec; 21(9):917-21. PubMed ID: 20970513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor.
    Clement JH; Sänger J; Höffken K
    Int J Cancer; 1999 Jan; 80(2):250-6. PubMed ID: 9935207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of epidermal growth factor receptors in human lung tumors.
    Hwang DL; Tay YC; Lin SS; Lev-Ran A
    Cancer; 1986 Nov; 58(10):2260-3. PubMed ID: 3489515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extracellular matrix protein 1 regulates cell proliferation and trastuzumab resistance through activation of epidermal growth factor signaling.
    Lee KM; Nam K; Oh S; Lim J; Kim YP; Lee JW; Yu JH; Ahn SH; Kim SB; Noh DY; Lee T; Shin I
    Breast Cancer Res; 2014 Dec; 16(6):479. PubMed ID: 25499743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of 1.25 dihydroxyvitamin D3 on binding and internalization of epidermal growth factor in cultures cells. Studies on BT-20 cells using quantitative electron microscope autoradiography.
    Frappart L; Lefebvre MF; Saez S
    Exp Cell Res; 1989 Oct; 184(2):329-41. PubMed ID: 2806396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor induces tyrosine phosphorylation of epidermal growth factor receptors not occupied with ligand in intact A431 cells.
    Sorokin AB; Reshetnikova GF; Kudryavtseva NV; Nikolsky NN
    FEBS Lett; 1990 Jul; 268(1):121-4. PubMed ID: 1696547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer.
    Sainsbury JR; Malcolm AJ; Appleton DR; Farndon JR; Harris AL
    J Clin Pathol; 1985 Nov; 38(11):1225-8. PubMed ID: 2999195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
    Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N
    Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.